Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Women Innovating Healthcare: Plum Alley Investments Funds EpiBone, An Early Stage Company Growing Human Bone
  • USA - English


News provided by

Plum Alley

Oct 18, 2016, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Andrea Turner Moffitt, Dr. Nina Tandon, and Deborah Jackson
Andrea Turner Moffitt, Dr. Nina Tandon, and Deborah Jackson

New York, NY (PRWEB) October 18, 2016 -- Today, Plum Alley Investments, a private membership supporting promising women entrepreneurs and gender-diverse teams, announces the closing of a $560k syndicate in EpiBone, a startup using stem cells to grow new bone. Alongside funders like Partnership Fund for NYC, Breakout Labs, and other noted angel and institutional investors, Plum Alley participated in the company’s recent multi-million capital raise.

[Plum Alley Investments] recognizes that we not only need to back gender-balanced teams, but also address gender balance at the structural level with investors

Post this

Featured on Bloomberg, CNBC, and CNN, EpiBone is a biotechnology company led by Dr. Nina Tandon seeking to revolutionize reconstructive bone surgery by enabling patients to generate bone from their own stem cells with the help of 3D printing and other digital fabrication technologies. EpiBone’s ultimate mission is to disrupt the current model of healthcare delivery based on pills and devices by creating a truly living therapy that reduces the need for multiple surgeries and improves patient outcomes.

Deborah Jackson and Andrea Turner Moffitt, the co-founders of Plum Alley Investments, are committed to building an inclusive and active ecosystem of women and men who value diversity and want to invest in companies shaping innovation. Recent research co-authored by Turner Moffitt and the Center for Talent Innovation reveals, “90% of women want to invest in companies that promote social well-being.” The same study shows that women control $11.2 trillion of investable assets as primary and joint decision makers, yet women have a significant amount of capital on the sidelines. Plum Alley provides the opportunity for a broader base of investors to become directly involved with purpose-driven companies like EpiBone.

“I first met Nina 18 months ago in my work on the committee of senior advisors who work with the President and Board of Columbia to direct the University in the field of entrepreneurship. We all know how important our networks are and the opportunity you have when the network is open to both women and men. As a founder of a company and as an investor, I see the momentum and value to more inclusive and robust networks,” said Deborah Jackson, CEO of Plum Alley.

CEO and co-founder of EpiBone Dr. Tandon believes that having a diverse base of investors and opening the access to more women investors is of critical importance. “We are thrilled to be working with Plum Alley, who recognizes that we not only need to back gender-balanced teams, but also address gender balance at the structural level with investors, to foster a broader, more connected ecosystem of founders and investors,” comments Dr. Tandon, who holds a PhD in Biomedical Engineering and an MBA from Columbia University.

Companies that accelerate positive change, embrace innovation and have strong business models are important to the growing base of Plum Alley members, which includes men and women with executive experience across Wall Street, technology, education, philanthropy, Fortune 500 companies, and a variety of industries.

“Plum Alley not only offered the visibility and access to EpiBone, but also a thoughtful, efficient and engaging investing experience,” shares member LeighAnne Baker, Corporate Vice President and Chief Human Resources Officer of Cargill, “I’ve been able to diversify my portfolio by investing in a promising biotech startup run by a female founder and CEO, which matches one of my investment goals.”

EpiBone marks Plum Alley Investments’ fourth syndicate. Within its first year, Plum Alley Investments has deployed $1.5 million in capital across four distinct sectors: unconscious bias software, education tech for children, marketplace private investigators, and regenerative medicine.

To learn more about EpiBone visit epibone.com.

About Plum Alley Investments:
Plum Alley Investments is a paid private membership committed to offering new and seasoned investors highly curated investment opportunities and a different investing experience both offline and online. Plum Alley Investments is part of Plum Alley, a company that has championed women entrepreneurs since 2011.

Members have access to private company investment syndicates, inspiring entrepreneurs, insights from seasoned investors, opportunities to collaborate with other members, and execute equity and debt investments.

For more information on Plum Alley Investments visit plumalley.co or contact sara(at)plumalley(dot)co.

Sara Reinis, Plum Alley, http://plumalley.co, +1 (512) 971-7703, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.